Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies
Open Access

HLA Class I Loss and Resistance to Immunotherapy in Pulmonary Metastasis of Hypopharyngeal Cancer

AKIRA MURAKAMI, KAORI YUKINO, YOSHIHIRO KOMOHARA, YU SHIMODA, HARUKI SAITO, YUKIO FUJIWARA and YORIHISA ORITA
In Vivo May 2026, 40 (3) 1753-1759; DOI: https://doi.org/10.21873/invivo.14327
AKIRA MURAKAMI
1Departments of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAORI YUKINO
1Departments of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIHIRO KOMOHARA
2Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ycomo{at}kumamoto-u.ac.jp
YU SHIMODA
1Departments of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HARUKI SAITO
1Departments of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUKIO FUJIWARA
2Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YORIHISA ORITA
1Departments of Otolaryngology-Head and Neck Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Clinical examination. (A) Laryngofiberscopic findings: Right vocal fold paralysis is noted, and airway stenosis is present because of compression by the hypopharyngeal carcinoma. (B) T1-weighted contrast-enhanced magnetic resonance imaging (B: axial) of hypopharyngeal carcinoma, likely originating from the right pyriform sinus, shows destruction of the thyroid cartilage. Multiple metastatic lymph nodes are noted in both sides of the neck. Lymph node metastases are seen in both sides of the neck. (C) Lung window computed tomography (CT) of a metastatic lesion in the left lung field. (D) Lung window CT of a new metastatic lesion appearing approximately three years after starting nivolumab therapy.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Pathological examination. Additional pathological analyses were performed using resected primary biopsy specimens and surgically resected pulmonary metastatic lesions. Hematoxylin and eosin staining and immunohistochemistry for CD3, CD8, CD103, CD163, PD-L1, HLA class I (A/B/C), B2M, and HLA-DR were conducted on serial sections. Representative images of the corresponding areas are shown. Scale bars=20 μm.

PreviousNext
Back to top

In this issue

In Vivo: 40 (3)
In Vivo
Vol. 40, Issue 3
May-June 2026
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
HLA Class I Loss and Resistance to Immunotherapy in Pulmonary Metastasis of Hypopharyngeal Cancer
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 10 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
HLA Class I Loss and Resistance to Immunotherapy in Pulmonary Metastasis of Hypopharyngeal Cancer
AKIRA MURAKAMI, KAORI YUKINO, YOSHIHIRO KOMOHARA, YU SHIMODA, HARUKI SAITO, YUKIO FUJIWARA, YORIHISA ORITA
In Vivo May 2026, 40 (3) 1753-1759; DOI: 10.21873/invivo.14327

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
HLA Class I Loss and Resistance to Immunotherapy in Pulmonary Metastasis of Hypopharyngeal Cancer
AKIRA MURAKAMI, KAORI YUKINO, YOSHIHIRO KOMOHARA, YU SHIMODA, HARUKI SAITO, YUKIO FUJIWARA, YORIHISA ORITA
In Vivo May 2026, 40 (3) 1753-1759; DOI: 10.21873/invivo.14327
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Case Report
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Acute Kidney Injury in Patients With Diabetes Mellitus: A Disproportionality Analysis Based on the FAERS
  • Expression Patterns of T-cell immunoreceptor With Ig and ITIM domains (TIGIT) in Classical Hodgkin Lymphoma: A Clinicopathological Study
  • Older Age and Outcomes of Intravesical Bacillus Calmette-Guérin for Non-muscle-invasive Bladder Cancer
Show more Clinical Studies

Keywords

  • immune checkpoint inhibitor
  • head and neck squamous cell carcinoma (HNSCC)
  • pulmonary metastasis
  • β2-microglobulin
  • immune escape
In Vivo

© 2026 In Vivo

Powered by HighWire